glp-1 colorectal cancer risk study november 2025 If you are taking a for diabetes or weight loss, a new found it may also be lowering your of colon cancer. Researchers analyzed health records for 281,000 people Frontiers | Reassessing cancer risk
Description
A University of Miami study found GLP1 therapy significantly improved freedom from atrial fibrillation after ablation in obese patients.
Combining metformin with GLP-1 medications like Ozempic may enhance weight loss and blood sugar control
In order to reveal the pathogenic mechanism of digestive diseases, it is necessary to establish a completer and more physiological organoid model
TUESDAY, Nov
Dementia risk was comparable between GLP1-RA versus SGLT2i in both intention-to-treat (HR 0.98, 95% CI 0.871.11
Learn how to safely restart semaglutide or tirzepatide after a break
